Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
WENTWORTH KORY JAMES
Chief Financial Officer at Entrada Therapeutics. Filing since 16 Aug 2022.
CIK 0001725663
Company
Date
Role
Action
Shares
Amount
Of holding
TRDA
Entrada Therapeutics, Inc.
1 Apr 2026
Chief Financial Officer
Sold on a plan
2,500
$32.38K
2.1%
TRDA
Entrada Therapeutics, Inc.
10 Mar 2026
Chief Financial Officer
Sold on a plan
11,388
$148.22K
8.6%
TRDA
Entrada Therapeutics, Inc.
9 Mar 2026
Chief Financial Officer
Sold on a plan
5,089
$66.16K
3.7%
TRDA
Entrada Therapeutics, Inc.
4 Mar 2026
Chief Financial Officer
Sold on a plan
7,988
$97.89K
5.5%
TRDA
Entrada Therapeutics, Inc.
21 Nov 2025
Chief Financial Officer
Sold on a plan
8,910
$88.93K
7.5%
TRDA
Entrada Therapeutics, Inc.
17 Mar 2025
Chief Financial Officer
Sold on a plan
1,784
$19.04K
1.6%
TRDA
Entrada Therapeutics, Inc.
2 Dec 2024
Chief Financial Officer
Sold on a plan
5,000
$99.98K
6.3%
TRDA
Entrada Therapeutics, Inc.
29 Nov 2024
Chief Financial Officer
Sold on a plan
1,000
$19.97K
1.3%
TRDA
Entrada Therapeutics, Inc.
11 Nov 2024
Chief Financial Officer
Sold on a plan
8,637
$172.56K
10.5%
TRDA
Entrada Therapeutics, Inc.
9 Sep 2024
Chief Financial Officer
Sold on a plan
3,195
$47.83K
4.0%
TRDA
Entrada Therapeutics, Inc.
8 Jul 2024
Chief Financial Officer
Sold on a plan
1,758
$26.28K
2.1%
TRDA
Entrada Therapeutics, Inc.
6 Mar 2024
Chief Financial Officer
Sold on a plan
4,086
$50.29K
5.2%
TRDA
Entrada Therapeutics, Inc.
26 Dec 2023
Chief Financial Officer
Sold on a plan
94
$1.57K
0.2%
TRDA
Entrada Therapeutics, Inc.
22 Dec 2023
Chief Financial Officer
Sold on a plan
10,206
$160.12K
17.1%
TRDA
Entrada Therapeutics, Inc.
21 Dec 2023
Chief Financial Officer
Sold on a plan
2,200
$33.15K
4.2%
TRDA
Entrada Therapeutics, Inc.
6 Sep 2023
Chief Financial Officer
Sold on a plan
950
$12.81K
1.9%
TRDA
Entrada Therapeutics, Inc.
11 Jul 2023
Chief Financial Officer
Sold on a plan
3,884
$69.90K
9.6%
TRDA
Entrada Therapeutics, Inc.
10 Jul 2023
Chief Financial Officer
Sold on a plan
6,116
$109.96K
14.3%
TRDA
Entrada Therapeutics, Inc.
21 Jun 2023
Chief Financial Officer
Sold on a plan
17,500
$262.65K
38.5%
TRDA
Entrada Therapeutics, Inc.
2 Mar 2023
Chief Financial Officer
Sold, plan not stated
1,747
$18.39K
4.0%
TRDA
Entrada Therapeutics, Inc.
8 Dec 2022
Chief Financial Officer
Sold, plan not stated
4,550
$86.24K
21.6%
TRDA
Entrada Therapeutics, Inc.
5 Dec 2022
Chief Financial Officer
Sold, plan not stated
200
$3.61K
1.2%
TRDA
Entrada Therapeutics, Inc.
2 Dec 2022
Chief Financial Officer
Sold, plan not stated
2,910
$52.95K
15.0%
TRDA
Entrada Therapeutics, Inc.
16 Nov 2022
Chief Financial Officer
Sold, plan not stated
200
$3.62K
1.2%
TRDA
Entrada Therapeutics, Inc.
25 Aug 2022
Chief Financial Officer
Sold, plan not stated
1,551
$21.99K
12.4%
TRDA
Entrada Therapeutics, Inc.
24 Aug 2022
Chief Financial Officer
Sold, plan not stated
3,118
$42.38K
19.9%
TRDA
Entrada Therapeutics, Inc.
23 Aug 2022
Chief Financial Officer
Sold, plan not stated
2,909
$38.08K
16.7%
TRDA
Entrada Therapeutics, Inc.
22 Aug 2022
Chief Financial Officer
Sold, plan not stated
217
$2.82K
1.3%
TRDA
Entrada Therapeutics, Inc.
19 Aug 2022
Chief Financial Officer
Sold, plan not stated
8,529
$111.53K
34.6%
TRDA
Entrada Therapeutics, Inc.
18 Aug 2022
Chief Financial Officer
Sold, plan not stated
200
$2.60K
1.0%
TRDA
Entrada Therapeutics, Inc.
17 Aug 2022
Chief Financial Officer
Sold, plan not stated
200
$2.61K
1.0%
TRDA
Entrada Therapeutics, Inc.
16 Aug 2022
Chief Financial Officer
Sold, plan not stated
200
$2.60K
1.0%
32 decisions on file.
